The SYNTAX trial of stent v CABG

October 8, 2008- by Steven E. Greer, MD

A trio of cardiac experts from Cedars Sinai Medical Center in Los Angeles discusses the SYNTAX trial that compared the safety end efficacy of drug eluting stenting versus CABG surgery in multivessel disease. Sanjay Kaul moderates cardiac surgeon Greg Fontana and interventional cardiology and cath lab director Raj Makkar.

This entry was posted in - Opinion, - Policy, Cardiac surgery, Cardiology, Cedars Sinai. Bookmark the permalink.

Leave a Reply

Your email address will not be published.